Neumora Therapeutics, Inc. (NMRA) stock

NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$0.43−0.00 (-0.95%)

Close on Nov 13, 2026Market cap $80.59MP/E –Yield –

Neumora Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Neumora Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?